
Watson International: A Global Leader in High-Purity PEG Linkers for Antibody-Drug Conjugate (ADC) Innovation
In the realm of modern biopharmaceutical innovation, antibody-drug conjugates (ADCs) represent a promising frontier—one that combines the specificity of monoclonal antibodies with the potency of cytotoxic agents. At the core of this technology lies a critical component: the linker, which bridges the antibody and the drug payload. Among the various types of linkers, polyethylene glycol